449
Participants
Start Date
March 31, 2011
Primary Completion Date
June 30, 2012
Study Completion Date
July 31, 2012
CD07805/47 gel 0.5%
In this open-label study, all subjects will receive treatment with CD07805/47 gel 0.5% applied once daily, for up to 12 months.
DermResearch Center of New York, Inc, Stony Brook
DermDox, Hazleton
Piedmont Medical Research, Winston-Salem
Metrolina Medical Research, Charlotte
Dermatology, Laser & Vein Specialists of the Carolinas, Charlotte
Wilmington Medical Research, Wilmington
Palmetto Medical Research, Mt. Pleasant
Gwinnett Clinical Research Center, Inc, Snellville
Rivergate Dermatology Clinical Research Center, PLLC, Goodlettsville
Tennessee Clinical Research Center, Nashville
East Tennessee Medical Research, Johnson City
TriCities Medical Research, Kingsport
Deaconess Clinic, Evansville
Hamzavi Dermatology, Fort Gratiot
Dermcenter PC- Somerset Skin Centre, Troy
Madison Skin & Research, Inc., Madison
Minnesota Clinical Study Center, Fridley
Compliant Clinical Research, Olathe
Skin Specialists, PC, Omaha
Arlington Center for Dermatology, Arlington
Dermatology Clinical Research Center of San Antonio, San Antonio
Progressive Clinical Research, PA, San Antonio
Cherry Creek Research, Inc, Denver
Longmont Clinical PC, Longmont
Dermatology Research Center, Salt Lake City
The Laser Institute for Dermatology, Santa Monica
Wenatchee Valley Medical Center - Clinical Research Department, Wenatchee
Lead Sponsor
Galderma R&D
INDUSTRY